Molecular testing is recommended to confirm the diagnosis in histologically or immunohistochemically equivocal cases and to exclude syndromic conditions (FAP) in patients with CTNNB1 wild-type DTs (IV, B). The gene discussed is CTNNB1; the disease is Familial adenomatous polyposis.